GlassScriptVoxzogo 1.2mg
Payments companies reported to CMS as associated with Voxzogo 1.2mg. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Voxzogo 1.2mg, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Voxzogo 1.2mg
These are the largest totals companies reported as associated with Voxzogo 1.2mg. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Philippe Backeljauw | Cincinnati, OH | Pediatric Endocrinology | $167,724.06 |
| Cathleen Raggio | Uniondale, NY | Pediatric Orthopaedic Surgery | $123,939.78 |
| Julie Hoover-Fong | Baltimore, MD | Clinical Genetics (M.D.) | $90,892.43 |
| Janet Legare | Madison, WI | Developmental - Behavioral Pediatrics | $59,728.94 |
| Andrew Dauber | Cincinnati, OH | Pediatric Endocrinology | $37,952.10 |
| Amrit Bhangoo | Long Beach, CA | Pediatric Endocrinology | $37,139.17 |
| Lawrence Silverman | Morristown, NJ | Pediatric Endocrinology | $34,375.24 |
| Ronald Rosenfeld | Broomall, PA | Orthopaedic Surgery | $30,458.54 |
| Aristides Maniatis | Centennial, CO | Pediatric Endocrinology | $29,759.03 |
| Klane White | Aurora, CO | Pediatric Orthopaedic Surgery | $26,185.98 |
Prescribed Voxzogo 1.2mg?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.